These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6432119)

  • 21. Effects of moderate salt restriction in hypertensive patients treated with oxprenolol or chlorthalidone.
    Pollavini G; Comi D; Grillo C; Lombardo M; Mantero O; Minetti L; Selvini A; Suppa G
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):451-5. PubMed ID: 6490228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium restriction and potassium supplementation in young people with mildly elevated blood pressure.
    Grobbee DE; Hofman A; Roelandt JT; Boomsma F; Schalekamp MA; Valkenburg HA
    J Hypertens; 1987 Feb; 5(1):115-9. PubMed ID: 3295034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of two doses of the fixed-combination chlorthalidone and slow-release metoprolol on blood pressure at rest and during exercise: a multicenter study.
    Caponnetto S; Alberti D; Bafico GL; Bertulla A; Camerieri A; Francucci BM; Gatto E; Gentile A; Livi S; Mereto PE
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):574-9. PubMed ID: 3781678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in blood pressure, serum potassium and electrolytes with a combination of triamterene and a low dose of chlorthalidone.
    Hort JF; Wilkins HM
    Curr Med Res Opin; 1991; 12(7):430-40. PubMed ID: 1778085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ramipril decreases chlorthalidone-induced loss of magnesium and potassium in hypertensive patients.
    Simunic M; Rumboldt Z; Ljutic D; Sardelic S
    J Clin Pharmacol; 1995 Dec; 35(12):1150-5. PubMed ID: 8750365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enalapril in essential hypertension: the comparative effects of additional placebo, nicardipine and chlorthalidone.
    Donnelly R; Elliott HL; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1987 Dec; 24(6):842-5. PubMed ID: 2830895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial.
    Parvanova A; Trillini M; Podestà MA; Iliev IP; Ruggiero B; Abbate M; Perna A; Peraro F; Diadei O; Rubis N; Gaspari F; Carrara F; Stucchi N; Belviso A; Bossi AC; Trevisan R; Remuzzi G; de Borst M; Ruggenenti P;
    Lancet Diabetes Endocrinol; 2018 Jan; 6(1):27-40. PubMed ID: 29104158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age and responses to isometric exercise in hypertension: possible predictors of the antihypertensive effect of diuretics and beta-blockers.
    Corea L; Valori C; Bentivoglio M; Verdecchia P; Bichisao E
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):554-9. PubMed ID: 2866164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-acting and short-acting diuretics in mild essential hypertension.
    Wing LM; West MJ; Graham JR; Chalmers JP
    Clin Exp Hypertens A; 1982; 4(8):1429-41. PubMed ID: 6749348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moderate potassium supplementation in essential hypertension.
    MacGregor GA; Smith SJ; Markandu ND; Banks RA; Sagnella GA
    Lancet; 1982 Sep; 2(8298):567-70. PubMed ID: 6125727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating hypertension in black compared with white non-insulin dependent diabetics: a double blind trial of verapamil and metoprolol.
    Cruickshank JK; Anderson NM; Wadsworth J; Young SM; Jepson E
    BMJ; 1988 Nov; 297(6657):1155-9. PubMed ID: 3144329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.
    Bakris GL; Sica D; White WB; Cushman WC; Weber MA; Handley A; Song E; Kupfer S
    Am J Med; 2012 Dec; 125(12):1229.e1-1229.e10. PubMed ID: 22939358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension.
    MacGregor GA; Markandu ND; Sagnella GA; Singer DR; Cappuccio FP
    Lancet; 1989 Nov; 2(8674):1244-7. PubMed ID: 2573761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension.
    Angelino PF; Alvino-Demartino A; Mappa R; Donati C
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):501-5. PubMed ID: 3902676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Moderate supplementation of potassium in essential hypertension].
    MacGregor GA; Smith SJ; Markandu ND; Banks RA; Sagnella GA
    Arch Mal Coeur Vaiss; 1984 Apr; 77 Spec No():93-100. PubMed ID: 6428368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of low-dose antihypertensive therapy in elderly patients with predominant systolic hypertension.
    Gray DR; Weber MA; Drayer JI
    J Gerontol; 1983 May; 38(3):302-6. PubMed ID: 6841923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
    Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the antihypertensive effects of betaxolol and chlorthalidone as monotherapy and in combination.
    Burris JF; Davidov ME; Jenkins P; Rofman B; Ginsberg D; Rosenbaum R; Ryan JR; Jain AK; Mroczek WJ
    Arch Intern Med; 1989 Nov; 149(11):2437-41. PubMed ID: 2684073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.
    Neaton JD; Grimm RH; Prineas RJ; Stamler J; Grandits GA; Elmer PJ; Cutler JA; Flack JM; Schoenberger JA; McDonald R
    JAMA; 1993 Aug; 270(6):713-24. PubMed ID: 8336373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.